Dyne Therapeutics DYN
NASDAQ DYN
$15.20 -0.62 (-3.92%)
At close: Oct 2, 2026 · 4:00 PM EDT

Dyne Therapeutics (DYN) Return on Assets [ROA] (2020 - 2026)

Updated

Dyne Therapeutics (DYN) recorded Return on Assets [ROA] of -48.91% in Q2 2026, up 7.69 percentage points from -56.60% a year earlier but down 9.86 percentage points from the prior quarter.

Analysis

Dyne Therapeutics (DYN) Return on Assets [ROA] (2020 - 2026) Analysis & Trends

For FY2025, Dyne Therapeutics reported Return on Assets [ROA] of -46.68%, up 27.35 percentage points from FY2024.

  • Annual Return on Assets [ROA] has a five-year change of -14.98 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Assets [ROA] came in at -74.03% in FY2024 (+25.47 pp), -99.50% in FY2023 (-53.58 pp), -45.91% in FY2022 (-7.59 pp) and -38.33% in FY2021 (-6.64 pp).
  • Quarterly Return on Assets [ROA] has ranged from -126.66% in Q4 2023 to -27.00% in Q3 2021 over the past five years.
  • On a year-over-year basis, Return on Assets [ROA] has increased for three consecutive quarters, with an average year-over-year change of +18.31 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Assets [ROA] in the last five years was a gain of 83.25 percentage points in Q4 2024, against a drop of 71.20 percentage points in Q4 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at -39.05% (Q1 2026), -42.97% (Q4 2025) and -52.93% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 10.47%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.65%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 28.37%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.10%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 9.29%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -6.13%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.14%
10 Dyne Therapeutics 2.52 Bn 2.52 Bn - -48.91%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -48.91%
Mar 31, 2026 -39.05%
Dec 31, 2025 -42.97%
Sep 30, 2025 -52.93%
Jun 30, 2025 -56.60%
Mar 31, 2025 -51.83%
Dec 31, 2024 -43.41%
Sep 30, 2024 -36.78%
Jun 30, 2024 -38.14%
Mar 31, 2024 -74.69%
Dec 31, 2023 -126.66%
Sep 30, 2023 -90.83%
Jun 30, 2023 -69.87%
Mar 31, 2023 -59.32%
Dec 31, 2022 -55.46%
Sep 30, 2022 -56.60%
Jun 30, 2022 -50.08%
Mar 31, 2022 -39.31%
Dec 31, 2021 -33.45%
Sep 30, 2021 -27.00%
API Access

Dyne Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=DYN&period=max&api_key=YOUR_API_KEY